BioCentury
ARTICLE | Clinical News

Myfortic mycophenolic acid regulatory update

September 14, 2009 7:00 AM UTC

Novartis issued a Dear Healthcare Professional letter warning that cases of pure red cell aplasia (PRCA) have been reported in patients treated with mycophenolate mofetil, a drug that is metabolized t...